After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. The current market capitalization of Caredx Inc is $513.41M. A total of 0.98 million shares were traded on the day, compared to an average of 1.06M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, CDNA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 20 BUYs and 29 SELLs from insiders. Insiders purchased 563,365 shares during that period but sold 91,680.
In the most recent transaction, Seeto Reginald sold 2,818 shares of CDNA for 6.91 per share on Oct 02. After the transaction, the insider now owns 479,164 company shares. In a previous transaction on Sep 05, Seeto Reginald sold 2,819 shares at 9.49 per share. CDNA shares that the insider owns now total 481,982.
Among the insiders who sold shares, Seeto Reginald disposed of 576 shares on Aug 14 at a per-share price of $8.89. This resulted in the insider holding 484,801 shares of CDNA after the transaction. In another insider transaction, Seeto Reginald sold 2,819 shares at $11.35 per share on Aug 02. Company shares held by the insider now total 486,051.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for CDNA in the last 3 months, the mean price target is $12.40 with high estimates of $15.00 and low estimates of $10.00. In terms of 52-week highs and lows, CDNA has a high of $17.89 and a low of $4.80.
As of this writing, CDNA has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.29. The company reported an EPS of -$0.18 in the last quarter, which was 41.90% higher than expectations of -$0.31.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $7.28, while its Total Shareholder’s Equity was $465.88M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.00.
